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Recurrent Uterine Cervical Carcinoma:
Spectrum of Imaging Findings
Uterine cervical carcinoma is one of the most common malignant tumors occur-
ring in females. After primary treatment, patients are usually followed up with CT
or MRI and the findings of these modalities may be the first sign of recurrent dis-
ease. Because earlier additional treatment by chemotherapy or radiation therapy
may improve the prognosis, the early detection of recurrent cervical carcinoma is
clinically important. In this article, we review the CT and MR imaging findings of
recurrent uterine cervical carcinoma, and assign them to one of four groups: a)
recurrence at the primary site, involving the intrapelvic organs, b) extension to the
pelvic side-wall, c) metastases to pelvic and extrapelvic lymph nodes, or d)
metastases to distant organs. A further contribution of CT and MR imaging is the
detection of hydronephrosis due to ureteral obstruction. The cases in each group
are illustrated and discussed, and since an awareness of the spectrum of imaging
findings of recurrent cervical carcinoma is likely to lead to its early detection, radi-
ologists should be familiar with the information presented.
espite the decreased incidence of cervical carcinoma associated with
widespread screening using Papanicolaou’s smear test, uterine cervical
carcinoma is still one of the most common gynecologic malignancies.
Even though patients now survive longer due to radiation therapy and more effective
chemotherapy, it is also one of the most frequent causes of death in women. In spite of
these advances in the methods of treatment, approximately 30% of women with inva-
sive cervical carcinoma die as a result of recurrent or persistent disease (1).
Recurrence is defined as local tumor regrowth or the development of distant metas-
tasis discovered six months or more after complete regression of the treated lesion,
and uterine cervical carcinoma often recurs within two years of treatment. The inci-
dence of recurrence depends primarily on tumor bulk and the stage of the disease at
presentation (1). About one-half of recurrences appear within the pelvis, but distant
metastases may develop in the lung and liver, and in bone and lymph nodes (2).
Conventional radiographic evaluations of these patients include chest radiography,
excretory urography, barium enema, and occasionally, lymphangiography. However,
improvements in cross-sectional imaging modalities such as CT or MR imaging offer
distinct advantages over conventional radiographic techniques, and nowadays, the fol-
low-up of treated cervical carcinoma usually involves the use of these modalities.
Because additional chemotherapy or radiation therapy can improve the prognosis, the
early detection of recurrent cervical carcinoma is important. In the interests of early
detection, radiologists should therefore be familiar with the spectrum of imaging find-
ings presented by this condition.
We retrospectively reviewed the CT and MR imaging findings of patients with recur-
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Drent cervical carcinoma, classifying them as one of four
types according to the site of recurrence: a) recurrence at
the primary site, involving the intrapelvic organs, b) recur-
rent mass at the pelvic side-wall, c) metastases to pelvic
and extrapelvic lymph nodes and d) metastases to a distant
organ or organs. In this article, we illustrate and discuss the
various CT and MR imaging findings for each group. 
RECURRENCE AT THE PRIMARY SITE
Recurrence at the primary site may involve the cervix,
uterus, vagina, parametria or ovary, and is the most com-
mon manifestation of recurrent cervical carcinoma (3-5).
The incidence of recurrence at the primary site varies with
the stage at presentation, histologic type, adequacy of ther-
apy used and host response. Kim et al. (5) reported a high-
er incidence of recurrence among patients treated by radia-
tion therapy than by surgery. Invasion of the urinary blad-
der and rectum, with or without fistula formation, is a se-
vere complication which can be demonstrated by CT or
MR imaging.
RECURRENCE AS A CENTRAL PELVIC MASS
The evaluation of CT and MR imaging findings of recur-
rence at the primary site requires an understanding of the
normal anatomy of the pelvis after hysterectomy. Axial
images show that the vaginal vault is located posterior to
the bladder and anterior to the rectum at or near the level
of the acetabula. It is roughly rectangular or oblong in
shape, and should be symmetric and sharply marginated
from surrounding fat. The bladder and loops of the small
intestine occupy the space just superior to this level (1).
The most common CT and MR imaging feature of recur-
rent tumor of the primary site is an irregular mass averag-
ing 4 7 cm in diameter between the bladder and rectum
(3). Central necrosis and irregular enhancement are com-
mon findings (Figs. 1, 2), but the lesion may be seen on CT
or MR imaging as an area of homogenous soft tissue densi-
ty. The vaginal vault may be the first site of recurrence.
INVASION OF THE BLADDER AND RECTUM
If CT reveals loss of the fat plane between the tumor and
the bladder or rectum, invasion of these entities (Figs. 3
and 4) has occurred. MR imaging provides superior soft-tis-
sue contrast, and its use may therefore more accurately de-
tect the occurrence of such invasion. A diagnosis of vesical
or rectal invasion by means of T2-weighted MR imaging
can involve loss of the normal low signal intensity of the
bladder or rectal wall continuous to the mass as well as the
loss of normal fat planes (6). Kim and Han (6) reported
that in depicting vesical invasion of the urinary bladder in
uterine cervical carcinoma, the sensitivity, specificity, and
accuracy of MR imaging was 83%, 100%, and 99%, re-
spectively. The MR imaging findings of vesical invasion in-
clude nodularity and irregularity of the bladder wall, mass-
es protruding into the bladder lumen, high signal intensity
of the anterior aspect of the posterior bladder wall, and ab-
normal soft-tissue strands in the uterovesical space, imply-
ing desmoplastic reaction (6). A fistula sometimes forms,
and urine or fecal material may be present in remaining
vagina.
HYDROMETRA DUE TO CERVICAL MASS
In patients who have not undergone hysterectomy, local
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Fig. 1. Recurrence at the vagina in a 41-year-old woman who un-
derwent hysterectomy and radiation therapy. CT scan reveals an
irregular mass (arrows) between the bladder and rectum, and the
presence of a centrally located low-attenuated area indicates
necrosis and peripheral enhancement. On the left, a double-pig-
tail ureteral stent (arrowheads) is visible.
Fig. 2. Recurrence at the uterus following radiation therapy with-
out hysterectomy in a 61-year-old-woman. CT scan shows a cen-
tral pelvic mass (arrows) replacing the uterus. The central low-at-
tenuated area represents necrosis.tumor recurrence or radiation fibrosis may cause obstruc-
tion of the cervical os, leading to hydrometra or pyometra
(Fig. 5) (1). The CT appearance is that of a symmetrically
enlarged uterus with a low-attenuation, non-enhancing
central mass. This central low attenuation and lack of con-
trast enhancement help differentiate an obstructed uterus
from other causes of uterine enlargement (2).
RECURRENT MASS AT PELVIC SIDE-WALL
Recurrent mass at the pelvic side-wall is another common
finding, and since it may or may not be accompanied by a
recurrent mass at the primary site (3, 5) (Fig. 6), is separate-
ly discussed. It is characterized either by direct continuation
of the mass to the pelvic side-wall by means of a linear
strand of soft tissue, and involving loss of the fat planes, or
by confluence of the solid mass and the muscle of the pelvic
wall (1) (Fig. 7). Pelvic bone can be destroyed by tumor in-
vasion (Fig. 8). A recurrent mass at the pelvic side-wall
most commonly occurs in the parametria adjacent to the
uterine corpus and additional lateral extension might occur
at the level of the cervix and vagina (1). Kim et al (5) re-
ported that the there is no significant difference in the inci-
dence of pelvic side-wall extension between patients who
undergo surgery and those treated by radiation therapy.
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Fig. 3. Recurrence at the primary site with posterior extension to the rectum in an 80-year-old woman who underwent radical hysterecto-
my.
A. T2-weighted axial MR image shows an irregular shaped, low signal mass between the bladder and rectum. The mass is continuous
with the rectal wall (arrows), and protrudes into the rectal lumen.
B. Barium enema shows luminal irregularity and mucosal destruction of the lateral wall of the rectum, indicating the invasion of rectal mu-
cosa (arrowheads).
AB
Fig. 4. Recurrence at the primary site, with invasion of the urinary
bladder, in a 41-year-old woman. T2-weighted sagittal MR image
reveals a large, necrotic mass in the vagina and uterine cervix. A
fistula (arrow) between the necrotic cavity of the mass and the
urinary bladder is clearly visible.LYMPH NODE METASTASIS
The rich cervical lymphatic network drains into the para-
metrial, external iliac (including obturator), internal iliac,
and lateral sacral lymph nodes, and from there, draining
proceeds into the common iliac and para-aortic nodes. The
lymphatic spread of uterine cervical carcinoma usually fol-
lows the pelvic pathway, the common route for the lym-
phatic spread of tumors of the pelvic organs, and one
which can be divided into the anterior, lateral, hypogastric,
and presacral sections. In uterine cervical carcinoma, the
lateral route is the most common (7).
In uterine cervical carcinoma, lymphatic involvement has
traditionally been separated into primary and secondary
nodal groups. The first of these consists of the paracervical,
parametrial, internal and external iliac, and obturator
nodes, while those comprised by the second include the
sacral, common iliac, inguinal and para-aortic (4). When
the secondary nodal group is involved, the prognosis wors-
ens. In this article, the system used to classify lym-
phadenopathy - namely, that this involves either pelvic or
extrapelvic lymphnode metastasis - is one suited to the use
of cross-sectional imaging techniques.
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Fig. 5. Hydrometra due to obstruction of the cervical os in a 57-year-old woman who underwent radiation therapy without hysterectomy.
A. T2-weighted axial MR image shows a low signal mass (arrows) located in the cervical portion of the uterus and anterior to the rectum. 
B. In the upper level than in A (also a T2-weighted image), a fluid-filled, dilated uterus is visible. The low signal intensity of fluid in the
uterine cavity implies the presence of highly proteineous material.
AB
Fig. 7. Pelvic side-wall extension with destruction of the pelvic
bone in a 60-year-old woman. CT image shows a necrotic mass
(arrows) with bulging contour in the posterior pelvic wall, and
sacral destruction has occurred.
Fig. 6. Pelvic side-wall extension with invasion of gluteal muscle
in a 28-year-old woman. CT scan demonstrates the presence of
a necrotic mass (arrows) in the posterolateral aspect of the uri-
nary bladder. The mass extends to the left posterior pelvic side-
wall and invades the gluteus muscle.PELVIC LYMPH NODE METASTASIS
The incidence of pelvic lymph node metastases in uterine
cervical carcinoma varies according to the size, extent and
histologic type of the primary tumor. A study by Walsh et
al (8) showed that in 38% of patients with central pelvic
recurrence, pelvic adenopathy was also present. The re-
ported accuracy rate for CT in detecting pelvic node
metastasis in patients with uterine cervical carcinoma
ranged between 73 and 83%, while the rate for MRI was
between 76 and 100% (9). The CT and MR imaging criteri-
on for positive lymph node is a minimal axial diameter of
at least 1 cm (10). The CT and MR imaging findings of
metastatic nodes vary, ranging from scattered and mini-
mally enlarged to large conglomerated masses (Fig. 9). A
finding of central necrosis is not helpful for differentiating
metastatic nodes from those that are non-metastatic and
hyperplastic (10). 
EXTRAPELVIC LYMPH NODE METASTASIS
Extrapelvic lymph nodes - particularly the supraclavicu-
lar, para-aortic, and inguinal, in decreasing order of fre-
quency - are common sites of distant metastasis (Fig. 10).
In many cases in which confirmed recurrent disease was
detected by CT, lymphadenopathy involved only the para-
aortic nodes (8). The incidence of recurrence at this site is
higher in patients treated by radiation therapy than in
those who undergo surgery, and this, as well as the higher
incidence of pelvic side-wall extension in such cases, is
probably because the tumor stage is generally more ad-
vanced and the field of radiation therapy is relatively nar-
row (5).
DISTANT METASTASIS
The common sites of distant metastasis are the lung,
bone, and the abdomen, in decreasing order of frequency,
though in cases of recurrent cervical carcinoma, the solid
organs of the abdomen are the most frequent sites of in-
volvement. In three separated autopsy series, pulmonary
metastasis from recurrent cervical carcinoma, which may
Choi et al.
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Fig. 9. Pelvic lymph node metastases.
A. Obturator node metastasis in a 36-year-old woman who underwent radical hysterectomy and radiation therapy. A peripherally enhanc-
ing, low-attenuated mass (arrows) attached to the right iliac bone and anterior to the pyriformis muscle is revealed by CT scanning.
Destruction of the pelvic bone is also visible.
B. Iliac node metastasis in a 52-year-old woman. Conglomerated, iso-attenuated masses (asterisk) are seen in the medial aspect of the
left iliac wing.
AB
Fig. 8. Pelvic side-wall extension without central pelvic mass in a
44-year-old woman who underwent hysterectomy. A round en-
hancing mass (arrow) is visualized anterior to the left pyriformis
muscle. The fat plane between the mass and the pyriformis mus-
cle is obliterated. In this patient, there is no evidence of recur-
rence at the primary site.Spectrum of Imaging Finding of Recurrent Uterine Cervical Carcinoma
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AB
Fig. 10. Extrapelvic node metastases.
A. Para-aortic node metastasis in a 45-year-old woman. CT scan
shows an enlarged para-aortic lymph node (asterisk), which in this
patient is the only site involved by recurrent disease.
B. Retroperitoneal lymph node metastasis in a 40-year-old woman.
Extensive lymphadenopathy in the para-aortic region and around
the celiac trunk is detected by CT. This lesion extends into the
splenic hilum (arrows).
C. Inguinal node metastasis. CT scan indicates the presence of an
enlarged right inguinal lymph node (arrow). Also note the presence
of swelling and soft tissue edema in the right lower extremity (ar-
rowheads) due to lymphatic and venous obstruction by metastatic
lymphadenopathy.
C
Fig. 11. Pulmonary metastases.
A. Hematolymphangitic metastasis in a 47-year-old woman. Lung window setting of the lower part of the lung demonstrates multiple nod-
ules and interlobular septal thickening.
B. Pulmonary metastasis manifested as mediastinal lymphadenopathy in a 45-year-old woman who two years earlier underwent hys-
terectomy. CT scan shows large mediastinal (para-aortic) lymph nodes (asterisk). Percutaneous needle biopsy confirmed that adenocar-
cinoma had metastasized from the uterine cervix.
ABexist for a significant period of time before becoming
symptomatic and may be either solitary or multiple, oc-
curred in 33 35% of cases (4). Typical patterns of lung in-
volvement are pulmonary nodules (71%), mediastinal and
hilar lymphadenopathy (32%), and pleural metastasis
(27%). Rare findings include endobronchial obstruction
(5%), and lymphangitic carcinomatosis (3%) (Fig. 11).
The spine, especially the lumbar spine, is the most com-
mon site of osseous metastasis. Involvement of the verte-
bral bodies, the mechanism of which is direct extension of
the tumor subsequent to para-aortic lymphadenopathy, is
most frequent, followed by that of the pelvis, ribs, and ex-
tremities (2).
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Fig. 12. Metastasis to the peritoneal cavity in a 48-year-old
woman. Abdominal CT scan indicates the presence of a mass
(arrow) with extensive central necrosis and lobulated contour in
the right upper quadrant. 
Fig.15. Splenic metastasis in a 53-year-old woman who under-
went hysterectomy. Enhanced CT scan reveals the presence in
the spleen of an ill-defined low-attenuated mass (arrow).
Fig. 13. Multiple hepatic metastases in a 44-year-old woman.
Contrast-enhanced T1-weighted axial MR image shows multiple,
target-shaped lesions with peripheral enhancement in the liver.
Fig. 14. Adrenal metastasis in a 61-year-old female. CT scan in-
dicates the presence in the right adrenal gland area of an oval-
shaped low-attenuated, 4 cm-sized mass (arrow). Needle biopsy
confirmed the occurrence of metastatic carcinoma.
Fig.16. Subcutaneous metastasis to a surgical scar in a 55-year-
old woman who underwent radical hysterectomy and radiation
therapy. CT scan shows a round heterogenous mass (arrow) in
subcutaneous abdominal tissue in the region of the scar.Abdominal metastasis occurred in the peritoneal cavity
(Fig. 12) and solid organs such as the liver (Fig. 13) and
adrenal gland (Fig. 14). Peritoneal metastasis, including
peritoneal carcinomatosis, is more common than metastasis
to the liver. The CT and MR imaging findings of metastases
to the peritoneal cavity are ascites, implants scalloping the
liver contour, peritoneal thickening with nodularity, and
soft tissue mass(4). The CT and MR imaging findings of he-
patic and adrenal involvement in recurrent cervical carci-
noma are non-specific and indistinguishable from involve-
ment by other primary malignancies. The involvement of
another solid abdominal solid organ such as the spleen
(Fig. 15), kidney, pancreas or gastrointestinal tract is rare,
and in almost all cases, widespread metastasis involving
other organs also occurs.
In the detection of abdominal recurrence, the most im-
portant problem related to the use of CT and MR imaging
is the fact that because the known pattern of spread of the
disease is through the iliac and aortic lymph nodes, most
such scanning routinely covers the region from the iliac
crests to the symphisis pubis. So that other recurrent le-
sions are not missed, scanning of a cervical neoplasm
should, however, include the upper abdomen.
The common primary sites in patients with skin or subcu-
taneous metastasis are the breast, colon, lung, and ovary;
skin metastasis from uterine cervical carcinoma is extreme-
ly rare. The most common sites of skin lesions are the ab-
dominal wall and vulva, followed by the anterior chest
wall, and in most patients there are multiple lesions.
Recurrence at the site of a surgical scar is rare, but is a pos-
sible complication of hysterectomy (Fig. 16). It is classified
as skin and subcutaneous involvement, and occurs mainly
in patients who have not undergone combined radiation
therapy or whose radiotherapeutic field did not include the
surgical scar.
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Fig.17. Hydronephrosis due to ureteral obstruction caused by re-
currence at the primary site in a 41-year-old woman who under-
went radical hysterectomy and radiation therapy. 
A. CT scan demonstrates hydronephrosis of the left kidney and
that the patient had undergone percutaneous nephrostomy of the
right kidney. A dilated left ureter (arrow) is depicted.
B. In the lower level than in A, dilated bilateral ureters (arrows) can
be traced.
C. Anterior to the rectum, an irregular shaped mass (arrowheads)
encased the dilated left ureter. Pelvic side-wall extension is also vi-
sualized.
CURETERAL OBSTRUCTION
Another contribution of CT and MR imaging in recurrent
uterine cervical carcinoma is the detection of ureteral ob-
struction, and determination of the etiology and level (3).
Such obstruction is due to the encasement or extrinsic com-
pression of a recurrent pelvic mass (Fig. 17) or metastatic
lymph nodes (Figs. 18, 19), or tumor infiltration of the blad-
der wall, which results in obstruction at the ureteral orifice.
The site of ureteral obstruction is usually revealed by scan-
ning of the retroperitoneal or pelvic area (3).
CONCLUSION
The recurrence of uterine cervical carcinoma can involve
various organs, with various patterns of imaging findings.
CT and MR imaging are the primary imaging modalities
used during the follow-up of treated cervical carcinoma.
Since the early detection of recurrent cancer makes for a
better prognosis, radiologists should be familiar with the
Choi et al.
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Fig. 18. Hydronephrosis due to ureteral obstruction by retroperitoneal lymph node metastasis in a 61-year-old woman. 
A. Enhanced CT scan shows bilateral hydronephrosis and decreased perfusion of the left kidney.
B. In the lower level than in A, a dilated right ureter (arrow) is visualized, and the presence of retroperitoneal lymphadenopathy is also vi-
su alized (arrowheads). 
AB
Fig. 19. Hydronephrosis due to ureteral obstruction by periureteral lymph node in a 49-year-old woman.
A. CT scan shows hydronephrosis of the left kidney, with decreased renal perfusion.
B. In the lower level than in A, a periureteral lymph node (arrow) obstructing the left ureter is depicted. The ureter can not be traced in this
level.
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spectrum of CT and MR imaging findings of recurrent uter-
ine cervical carcinoma. Recurrence which is extrapelvic or
involves the pelvic side-wall is more common in patients
who undergo radiation therapy only, a fact probably due
to the more advanced stage of the disease in such patients
and the limited field within which radiation therapy is pos-
sible. More careful examination is, therefore, necessary for
the patients treated by radiation therapy only. In the eval-
uation of pelvic malignancies, including uterine cervical
carcinoma, careful examination of the upper abdomen is
required in addition to routine pelvic scanning.
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